Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alleyne

Showing results (461-470 of 474) with videos related to

Pageof 48
Sort By:
JAMA|May 23, 2023
Reducing Opioid Use for Chronic Pain With a Group-Based Intervention: A Randomized Clinical TrialHarbinder K Sandhu, Katie Booth, Andrea D Furlan, et al.
Salud Publica De Mexico|November 7, 2015
[Global health 2035: a world converging within a generation]Dean T Jamison, Lawrence H Summers, George Alleyne, et al.
ACS Medicinal Chemistry Letters|January 8, 2019
Discovery of Orally Bioavailable and Liver-Targeted Hypoxia-Inducible Factor Prolyl Hydroxylase (HIF-PHD) Inhibitors for the Treatment of AnemiaPing Liu, Liping Wang, Byron G DuBois, et al.
Bioorganic & Medicinal Chemistry Letters|November 6, 2016
Discovery of benzofuran propanoic acid GPR120 agonists: From uHTS hit to mechanism-based pharmacodynamic effectsMatthew Lombardo, Kate Bender, Clare London, et al.
Science (New York, N.Y.)|December 18, 2004
Radio and plasma wave observations at Saturn from Cassini's approach and first orbitD A Gurnett, W S Kurth, G B Hospodarsky, et al.
Journal of Medicinal Chemistry|November 10, 2020
Series of Novel and Highly Potent Cyclic Peptide PCSK9 Inhibitors Derived from an mRNA Display Screen and Optimized via Structure-Based DesignCandice Alleyne, Rupesh P Amin, Bhavana Bhatt, et al.
Journal of Medicinal Chemistry|October 27, 2021
A Series of Novel, Highly Potent, and Orally Bioavailable Next-Generation Tricyclic Peptide PCSK9 InhibitorsThomas J Tucker, Mark W Embrey, Candice Alleyne, et al.
Health Technology Assessment (Winchester, England)|May 15, 2026
Effects and costs of a group-based educational intervention to reduce opioid use in people with chronic pain: I-WOTCH RCTHarbinder K Sandhu, Katie Booth, Sheeja Manchira Krishnan, et al.
Nature Communications|March 4, 2025
AAV9-mediated MYBPC3 gene therapy with optimized expression cassette enhances cardiac function and survival in MYBPC3 cardiomyopathy modelsAmara Greer-Short, Anna Greenwood, Elena C Leon, et al.
ACS Medicinal Chemistry Letters|January 21, 2017
Design, Synthesis, and Evaluation of Novel and Selective G-protein Coupled Receptor 120 (GPR120) Spirocyclic AgonistsJason M Cox, Hong D Chu, Mariappan V Chelliah, et al.
Pageof 48

Showing results (461-470 of 474) with videos related to

Sort By:
Pageof 48
JAMA|May 23, 2023
Reducing Opioid Use for Chronic Pain With a Group-Based Intervention: A Randomized Clinical TrialHarbinder K Sandhu, Katie Booth, Andrea D Furlan, et al.
Salud Publica De Mexico|November 7, 2015
[Global health 2035: a world converging within a generation]Dean T Jamison, Lawrence H Summers, George Alleyne, et al.
ACS Medicinal Chemistry Letters|January 8, 2019
Discovery of Orally Bioavailable and Liver-Targeted Hypoxia-Inducible Factor Prolyl Hydroxylase (HIF-PHD) Inhibitors for the Treatment of AnemiaPing Liu, Liping Wang, Byron G DuBois, et al.
Bioorganic & Medicinal Chemistry Letters|November 6, 2016
Discovery of benzofuran propanoic acid GPR120 agonists: From uHTS hit to mechanism-based pharmacodynamic effectsMatthew Lombardo, Kate Bender, Clare London, et al.
Science (New York, N.Y.)|December 18, 2004
Radio and plasma wave observations at Saturn from Cassini's approach and first orbitD A Gurnett, W S Kurth, G B Hospodarsky, et al.
Journal of Medicinal Chemistry|November 10, 2020
Series of Novel and Highly Potent Cyclic Peptide PCSK9 Inhibitors Derived from an mRNA Display Screen and Optimized via Structure-Based DesignCandice Alleyne, Rupesh P Amin, Bhavana Bhatt, et al.
Journal of Medicinal Chemistry|October 27, 2021
A Series of Novel, Highly Potent, and Orally Bioavailable Next-Generation Tricyclic Peptide PCSK9 InhibitorsThomas J Tucker, Mark W Embrey, Candice Alleyne, et al.
Health Technology Assessment (Winchester, England)|May 15, 2026
Effects and costs of a group-based educational intervention to reduce opioid use in people with chronic pain: I-WOTCH RCTHarbinder K Sandhu, Katie Booth, Sheeja Manchira Krishnan, et al.
Nature Communications|March 4, 2025
AAV9-mediated MYBPC3 gene therapy with optimized expression cassette enhances cardiac function and survival in MYBPC3 cardiomyopathy modelsAmara Greer-Short, Anna Greenwood, Elena C Leon, et al.
ACS Medicinal Chemistry Letters|January 21, 2017
Design, Synthesis, and Evaluation of Novel and Selective G-protein Coupled Receptor 120 (GPR120) Spirocyclic AgonistsJason M Cox, Hong D Chu, Mariappan V Chelliah, et al.
Pageof 48